Live Breaking News & Updates on மார்க் அர்ச்சம்பல்

Stay updated with breaking news from மார்க் அர்ச்சம்பல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The controversial approval of an Alzheimer's drug reignites the battle over the underlying cause of the disease

The controversial approval of an Alzheimer’s drug reignites the battle over the underlying cause of the disease
Laurie McGinley
© Jessica Rinaldi/Pool/Via Reuters
Marc Archambault, who has early-stage Alzheimer s disease, receives his first dose Wednesday of the newly approved intravenous drug Aduhelm at Butler Hospital in Providence, R.I. (Jessica Rinaldi/Pool/Reuters)
Neurologist Matthew S. Schrag was surprised when he heard the Food and Drug Administration had approved a controversial Alzheimer’s drug. There was scant evidence the treatment worked, in his view.
Even more concerning to Schrag: the FDA’s apparent embrace of a long-debated theory about Alzheimer’s disease, which afflicts more than 6 million Americans. The amyloid hypothesis, which has dominated the field for decades, holds that toxic clumps in the brain, called amyloid beta, are the main driver of the disease and that removing them will slow cognitive decline. ....

University Of Southern California , United States , Rhode Island , Gil Rabinovici , Peter Stein , Dennis Gibbs , Janet Woodcock , Vanderbilt Schrag , Eli Lilly , Alfred Sandrock Jr , Marc Archambault , Matthews Schrag , Halima Amjad , Jason Karlawish , Paula Newhouse , Alois Alzheimer , Paul Aisen , Ri Jessica Rinaldi , Johns Hopkins University , Vanderbilt University Medical Center , Members Of Congress , Drug Administration , Drug Administration On , Office Of New Drugs , University Of California At San Francisco , University Of Pennsylvania ,

The Health 202: The FDA could boost vaccinations by fully approving Pfizer's vaccine

The Health 202: The FDA could boost vaccinations by fully approving Pfizer's vaccine
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

United States , American Hospital Association , District Of Columbia , University Of California Hastings College The Law , White House , Nick Miroff , Rachel Cohrs , Anthonys Fauci , Laurie Mcginley , Adam Glanzman Bloomberg , Joseph Ross , Rachel Chason , Xavier Becerra , Matthews Schrag , Caroline Anders , Sean Sullivan , Amyb Wang , Stefani Reynolds Bloomberg , Eric Topol , Marc Archambault , Paige Winfield Cunningham , Dorit Rubinstein Reiss , Ri Jessica Rinaldi , Ashish Jha , Hannah Natanson , University Of California ,

The controversial approval of an Alzheimer's drug reignites the battle over the underlying cause of the disease

The controversial approval of an Alzheimer's drug reignites the battle over the underlying cause of the disease
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

University Of Southern California , United States , Rhode Island , Gil Rabinovici , Peter Stein , Dennis Gibbs , Janet Woodcock , Vanderbilt Schrag , Eli Lilly , Alfred Sandrock Jr , Marc Archambault , Halima Amjad , Jason Karlawish , Alois Alzheimer , Paula Newhouse , Paul Aisen , Johns Hopkins University , Vanderbilt University Medical Center , Members Of Congress , Office Of New Drugs , University Of California At San Francisco , University Of Pennsylvania , Vanderbilt University Medical , New Drugs , San Francisco , Butler Hospital ,

The wrong way to tackle the scourge of Alzheimer's disease

The wrong way to tackle the scourge of Alzheimer's disease
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

United States , Saint George , Saint Vincent And The Grenadines , Marc Archambault , Lisa Williams , Centers For Disease , While The National Institutes Of Health , Drug Administration , South Kingstown , Butler Hospital , Globe Staff Marc Archambault , National Institutes , Biden White House , Disease Control , ஒன்றுபட்டது மாநிலங்களில் , துறவி ஜார்ஜ் , துறவி வின்சென்ட் மற்றும் தி கிரெனடைன்கள் , மார்க் அர்ச்சம்பல் , லிசா வில்லியம்ஸ் , மையங்கள் க்கு நோய் , போது தி தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , தெற்கு கிக்ஸ்‌டௌந் , பட்லர் மருத்துவமனை , தேசிய நிறுவனங்கள் , பிடென் வெள்ளை வீடு , நோய் கட்டுப்பாடு ,

FDA releases fresh details on internal debate over controversial Alzheimer's drug

FDA releases fresh details on internal debate over controversial Alzheimer’s drug
Laurie McGinley
© Jessica Rinaldi/Pool/Via Reuters
Marc Archambault, who has early-stage Alzheimer s disease, receives his first dose Wednesday of the newly approved intravenous drug Aduhelm at Butler Hospital in Providence, R.I. (Jessica Rinaldi/Pool/Reuters)
The Food and Drug Administration on Tuesday released fresh details on why it approved a controversial Alzheimer’s drug in hopes of quelling a fierce debate over whether the agency should have cleared the costly treatment.
But the new information, included in interviews with agency officials and 83 pages of internal documents, might not quiet a furor over the drug Aduhelm that has drawn in Alzheimer’s doctors and patients, members of Congress, Medicare officials, and the agency itself. ....

United States , White House , District Of Columbia , Peter Stein , Aaron Kesselheim , Janet Woodcock , Matthew Schrag , Marc Archambault , Jamese Galvin , Ri Jessica Rinaldi , Patrizia Cavazzoni , Drug Administration On , Office Of New Drugs , Vanderbilt University Medical Center , University Of Miami , Harvard Medical School , Butler Hospital , Via Reuters Marc Archambault , Drug Administration , New Drugs , Drug Evaluation , President Biden , ஒன்றுபட்டது மாநிலங்களில் , வெள்ளை வீடு , மாவட்டம் ஆஃப் கொலம்பியா , பீட்டர் ஸ்டீன் ,